For patients with diabetes, what is the target HbA1c level?

The target HbA1c level for patients with diabetes is set at below 7%. This goal is widely endorsed by major diabetes management guidelines, including those from the American Diabetes Association and the Royal Australian College of General Practitioners. Maintaining an HbA1c level below 7% is associated with a reduced risk of long-term complications related to diabetes, such as cardiovascular disease, neuropathy, nephropathy, and retinopathy.

This target is appropriate for many adult patients with diabetes, particularly for those at increased risk of complications, as it balances the benefits of glycemic control with the risk of potential adverse effects from overly aggressive treatment, such as hypoglycemia. Individualized treatment goals may vary based on factors such as age, duration of diabetes, and presence of co-morbid conditions, but the general guideline supports the HbA1c target of below 7% for effective management and prevention of complications.